Search - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly

Filter your results

15 Results
Document type : Journal articles
Document type : Conference papers
Document type : Conference poster
Document type : Books
Document type : Book sections
Document type : Directions of work or proceedings
Document type : Patents
Document type : Other publications
labStructName_t : Groupe d'Etude de la Thrombose de Bretagne Occidentale

Cytotoxic effect of hyperthermia and chemotherapy with platinum salt on ovarian cancer cells: results of an in vitro study.

Matthieu Muller , Michel Chérel , Pierre-François Dupré , Sébastien Gouard , Michel Collet , et al.
European Surgical Research, 2011, 46 (3), pp.139-47. ⟨10.1159/000324395⟩
Journal articles hal-00931234v1

Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.

Pierre-Yves Le Roux , Thomas Gastinne , Steven Le Gouill , Emmanuel Nowak , Caroline Bodet-Milin , et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 (6), pp.1064-71. ⟨10.1007/s00259-011-1741-0⟩
Journal articles istex hal-00749883v1

The cytotoxic effect of combined hyperthermia and taxane chemotherapy on ovarian cancer cells: results of an in vitro study.

Matthieu Muller , M. Chérel , Pierre-François Dupré , S. Gouard , M. Collet , et al.
European Surgical Research, 2012, 48 (2), pp.55-63. ⟨10.1159/000333393⟩
Journal articles hal-00932168v1

Balanced transmission of a paternal complex chromosomal rearrangement involving chromosomes 2, 3, and 18.

Audrey Basinko , Aurore Perrin , Huyen Anh Nguyen , Frédéric Morel , Marie-Josée Le Bris , et al.
American Journal of Medical Genetics Part A, 2010, 152A (10), pp.2646-50. ⟨10.1002/ajmg.a.32982⟩
Journal articles istex hal-00927568v1

Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma.

Pierre-Yves Salaun , Caroline Bodet-Milin , Eric Frampas , Aurore Oudoux , Catherine Saï-Maurel , et al.
Cancer, 2010, 116 (4 Suppl), pp.1053-8. ⟨10.1002/cncr.24792⟩
Journal articles hal-00930166v1

Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer.

Françoise Kraeber-Bodéré , Pierre-Yves Salaun , Aurore Oudoux , David M Goldenberg , Jean-François Chatal , et al.
Cancer, 2010, 116 (4 Suppl), pp.1118-25. ⟨10.1002/cncr.24800⟩
Journal articles hal-00930004v1

¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.

Pierre-Yves Salaun , Loïc Campion , Catherine Ansquer , Eric Frampas , Cédric Mathieu , et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 (8), pp.1501-1510
Journal articles hal-01111285v1

[Quantitative assessment of medical students' clinical practical learning in department of obstetrics and gynecology of Brest Hospital University].

Matthieu Muller , X. Monfort , Pierre-François Dupré , Paul Amouroux , R. Tétefort , et al.
Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2011, 40 (6), pp.564-8. ⟨10.1016/j.jgyn.2011.01.005⟩
Journal articles hal-00931262v1

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

P. Saiag , R. Gutzmer , P. Ascierto , M. Maio , J.-J. Grob , et al.
Blood, 2016, 127 (14), pp.1761-1769
Journal articles hal-02043874v1

Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.

Pierre-Yves Salaun , Loïc Campion , Claire Bournaud , Alain Faivre-Chauvet , Jean-Philippe Vuillez , et al.
Journal of Nuclear Medicine, 2012, 53 (8), pp.1185-92. ⟨10.2967/jnumed.111.101865⟩
Journal articles hal-00932253v1

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.

Caroline Bodet-Milin , Ludovic Ferrer , Aurore Rauscher , Damien Masson , Latifa Rbah-Vidal , et al.
Frontiers in Medicine, 2014, 2, pp.84. ⟨10.3389/fmed.2015.00084⟩
Journal articles hal-01258870v1

Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).

Françoise Kraeber-Bodéré , Pierre-Yves Salaun , Catherine Ansquer , Delphine Drui , Eric Mirallié , et al.
Tumor Biology, 2012, 33 (3), pp.601-6. ⟨10.1007/s13277-012-0359-6⟩
Journal articles hal-00932128v1

Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?

Pierre y Salaun , Thomas Gastinne , Caroline Bodet-Milin , Loïc Campion , Pierre Cambefort , et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 (11), pp.1813-21. ⟨10.1007/s00259-009-1183-0⟩
Journal articles istex hal-00927531v1

T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study.

Géraldine Gallot , Solène Vollant , Soraya Saïagh , Béatrice Clémenceau , Régine Vivien , et al.
Journal of Immunotherapy, 2014, 37 (3), pp.170-9. ⟨10.1097/CJI.0000000000000031⟩
Journal articles hal-01256575v1

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Ronan Abgral , Solène Querellou , Gaël Potard , Pierre-Yves Le Roux , Alexandra Le Duc-Pennec , et al.
Journal of Nuclear Medicine, 2009, 50 (1), pp.24-9. ⟨10.2967/jnumed.108.055806⟩
Journal articles hal-00922914v1